BACKGROUND: This cost analysis uses data from a randomized trial comparing a no prophylaxis versus prophylactic platelet (PLT) transfusion policy (counts <10 × 10(9) /L) in adult patients with hematologic malignancies. Results are presented for all patients and separately for autologous hematopoietic stem cell transplantation (HSCT) (autoHSCT) and chemotherapy/allogeneic HSCT (chemo/alloHSCT) patients. STUDY DESIGN AND METHODS: Data were collected to 30 days on PLT and red blood cell (RBC)...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
If you are the owner of this record, you can report an update to it here: Report update to this record